4.5 Review

IL-23 and IL-17 in tuberculosis

期刊

CYTOKINE
卷 41, 期 2, 页码 79-83

出版社

ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
DOI: 10.1016/j.cyto.2007.11.022

关键词

tuberculosis; cytokines; inflammation

资金

  1. NIAID NIH HHS [P01 AI046530, R01 AI067723, R01 AI067723-02, AI46530, P01 AI046530-050004, AI067723, U54 AI057158, AI057158] Funding Source: Medline
  2. NIA NIH HHS [R21 AG028878-01, R21 AG028878, AG028878] Funding Source: Medline

向作者/读者索取更多资源

Tuberculosis is a chronic disease requiring the constant expression of cellular immunity to limit bacterial growth. The constant expression of immunity also results in chronic inflammation, which requires regulation. While IFN-gamma-producing CD4+ T helper cells (Th1) are required for control of bacterial growth they also initiate and maintain a mononuclear inflammatory response. Other T cell subsets are induced by Mycobacterium tuberculosis (Mtb) infection including those able to produce IL-17 (Th17). IL-17 is a potent inflammatory cytokinecapable of inducing chemokine expression and recruitment of cells to parenchymal tissue. Both the IL-17 and the Th17 response to Mtb are largely dependent upon IL-23. Although both Th17 and Thl cells are induced following primary infection with Mtb, the protective response is significantly altered in the absence of Thl cells but not in the absence of Th17. In contrast, in vaccinated animals the absence of memory Th17 cells results in loss of both the accelerated memory Thl response and protection. Thl and Th17 responses cross-regulate each other during mycobacterial infection and this may be important for immunopathologic consequences not only in tuberculosis but also other mycobacterial infections. (C) 2007 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据